The first cohort of students started the course in September 2014 and graduated in July 2019 this year. During that time, the College worked with the University to make sure its programme was developed to meet RCVS standards. That included interim visitations by a team of accreditation reviewers and a final accreditation visitation by representatives of the RCVS, the Australasian Veterinary Boards Council (AVBC) and the South African Veterinary Council (SAVC).
After the final visitation, a report was submitted to the RCVS Primary Qualifications Subcommittee (PQSC), which then recommended to the Education Committee that the RCVS recognises the University of Surrey’s veterinary degree (subject to satisfactory external examiner reports, which were subsequently received). In turn, the RCVS Council then approved the degree last week.
Dr Sue Paterson, the Chair of the Education Committee, said: "We are very glad to have reached the stage where we can formally welcome the University of Surrey on board as the eighth UK veterinary school to offer an approved degree, and that we will, from now on and pending Privy Council’s approval, be able to welcome its graduates onto the Register as proud members of the RCVS.
"We appreciate the immense hard work of both the faculty and the student body over the past five years in working to meet the College’s stringent accreditation standards and the effort that they have made to address our feedback and advice in a constructive and engaged way.
"When I observed at the final accreditation visit earlier this year I, along with the other visitors, was particularly impressed with the enthusiasm and commitment of the staff, the network of partner veterinary practices and the student body to the school’s ethos and success. We also recognised that, with its unique ‘distributive model’ meaning that students can get direct clinical experience across 49 veterinary practice partners, the students have access to a large and diverse medical and surgical caseload.
"The final report contained a number of further recommendations and we look forward to continuing to work with the school over the next two years to help them meet our recommendations and suggestions."
Professor Chris Proudman, Head of School of Veterinary Medicine at the University of Surrey, added: "I am delighted that our new degree programme in veterinary medicine and science has been approved by RCVS Council for recognition by the Privy Council.
"This decision recognises the huge investment in veterinary education made by the university and the quality of the education that we offer. It is also validation of our innovative model of delivering clinical teaching through working in partnership with clinical practices and other organisations involved in animal health, which has proven very popular with our students."
“The commitment and enthusiasm of our partners has been truly inspiring and energising. I look forward to Surrey veterinary graduates making valuable contributions to the profession in a variety of ways over the coming years.”
A Recognition Order to recognise the University of Surrey’s Bachelor of Veterinary Medicine and Science (BVMSci Hons) will now be put before the Privy Council and, if it approves the Order, this will then be laid before Parliament. If the Order is approved by both the Privy Council and Parliament, the University of Surrey will then enter the cyclical RCVS accreditation process and be subject to annual monitoring.
The executive summary of the final visitation report can be found in the papers for the October 2019 meeting of RCVS Council: https://www.rcvs.org.uk/who-we-are/rcvs-council/council-meetings/3-october-2019/. The full report will be published in due course.
Picture shows:(from left to right) Dr Susan Paterson, Chair of the RCVS Education Committee; Professor Chris Proudman, Head of School of Veterinary Medicine at the University of Surrey; and Dr Niall Connell, RCVS President.
BCF Technology has launched a series of free canine X-ray positioning guides which are now available to download from www.bcftechnology.com.
The company says the guides are designed to provide a quick, easy-to-use reference to help you get the best radiographic views possible, every time.
BCF in-house radiographer Kat Evans said: "At BCF, we understand that capturing a great X-ray isn't just about having the best equipment; good positioning is crucial, these easy-to-use guides will help vets and vet nurses to create the very best radiograph."
BCF in-house vet Ben Sullivan added: "At BCF we are committed to improving the standards of radiography in the veterinary profession. We aim to help our customers make the very most of their equipment. This is why we are committed to supporting ongoing education and training. You will find a huge range of learning materials on our website aimed at helping you to develop further your veterinary ultrasonography and radiography abilities.
Full small animal and equine positional guides are in-built into the software of all CR X-ray systems available from BCF.
For more information, visit www.bcftechnology.com or call +44(0)1506 460 023.
Boehringer Ingelheim Vetmedica has added a cardiology CPD section to its Vetmedin website. The section also includes a number of owner education resources to be used in practice.
The site, which is billed as a one-stop-shop on canine heart disease, includes an interactive radiology viewer, the Vetmedin atlas of cardiac radiology, radiology interpretation and diagnosis, an interactive MVD seminar and online downloadable Vetmedin dosage calculator to assist veterinary surgeons in prescribing the optimum dose.
Owner education materials include an animation explaining how to monitor a dog's resting respiratory rate, a video about heart failure and downloadable charts to help owners monitor their dog's condition.
For further information, visit www.vetmedin.co.uk, contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
Mr Samuel had been removed from the Register in 2018 for causing unnecessary harm to numerous animals.
After being tried and convicted of several animal welfare offences alongside his former partner at Leeds Magistrates Court, Mr Samuel was sentenced to 12 weeks’ imprisonment, suspended for 12-months on the condition that he did 150 hours of unpaid work.
He was also ordered to pay a £100 fine and subjected to a disqualification order under the Animal Welfare Act for three years.
Mr Samuel’s application for restoration was based on the facts that he accepted the seriousness of his actions and that he did not challenge the DC’s 2018 decision.
The Committee also heard evidence that since his removal from the Register, Mr Samuel - who had run a first opinion veterinary practice for nine years prior to being struck off - has undertaken 340 hours of work experience with other veterinary surgeons and 20 hours of CPD.
Dr Samuel was represented by Counsel who outlined in his submissions to the Committee how Dr Samuel’s former partner had sole responsibility for the animals and that she was involved in rehoming dogs and cats and that their relationship was ‘stressful’, that this made Dr Samuel neglect his professional obligations, and that Dr Samuel was now in a different relationship and his life had been ‘transformed’ since his conviction.
The College opposed Dr Samuel being restored to the Register.
Ms Curtis, Counsel on behalf of the College, submitted to the Committee that Dr Samuel continued to represent a risk to the welfare of animals and that to allow him to be restored to the Register would undermine public confidence in the profession.
She explained that even though his sentence and Animal Welfare Act Disqualification Order had come to an end, and he was now legally able to own animals, this should not be equated with him now being fit to return to the Register.
Dr Austin Kirwan MRCVS, chairing the Committee, and speaking on its behalf, said: “Where a veterinary surgeon has shown himself to be capable of such indifference to the welfare of multiple animals, there remained, in the Committee’s view, a real risk of that indifference manifesting itself again.
"A registered veterinary surgeon is entrusted with the care of animals, often when they are at their most vulnerable, and sometimes for prolonged periods of time.
"Given the nature of the animal welfare offences committed by Dr Samuel, the Committee considered there would be a real and significant risk to animals if the high level of responsibility and trust that comes with registration were returned to him.
“For a veterinary surgeon, conduct involving neglect of animals is at the highest end of the spectrum of serious professional misconduct.
"For the reasons outlined above, the Committee considered Dr Samuel continued to represent a risk to animal welfare and thus allowing him to be restored to the Register would seriously undermine public confidence in the profession.
"For all these reasons the application to restore Dr Samuel to the Register is refused.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
Eurovet Animal Health Ltd has entered the UK veterinary pharmaceuticals market with a portfolio of products including a levothyroxine tablet for the treatment of canine hypothyroidism, injectables for cattle and pigs, a xylazine injection for use in cattle, horses, dogs & cats and a corticosteroid for use in horses, cattle, pigs, cats and dogs.
Eurovet Animal Health is a subsidiary of Dutch company, AUV, which was established in 1969 as a cooperative by 100 veterinary surgeons, and is now jointly owned by 2000 vets. The company says this gives it a unique perspective on the products that veterinary surgeons really need and want. And whilst Eurovet Animal Health is still relatively small in the UK, the parent company Eurovet Animal Health BV owns state-of-the-art manufacturing facilities and provides access to international expertise, support and resources.
Eurovet Animal Health Ltd will be offering Eurovet products previously distributed by partner companies in the UK, so vets can expect to see brands they know and trust, as well as new brands. Existing products will be available from veterinary wholesalers and include:
Further information about Eurovet's range of products is available from Eurovet Animal Health, Compass House, Chivers Way, Histon, Cambridge, CB24 9AD Tel: 01223 257933 E-mail office@eurovet-ah.co.uk http://www.eurovet-ah.co.uk/
It's a subject that will be front of many people's minds following the recent cases of equine flu.
As part of the campaign, MSD has produced a range of veterinary practice support materials to help you engage with owners and yards on the subject of preventative healthcare best practice and compliance.
The range includes shareable social media content, videos, a 'What's Your Risk' practice poster, an online risk assessment tool and a number of downloadable information leaflets. Practices will also be supported through the Keep Britain's Horses Health (KBHH) web page, Facebook page and Twitter.
MSD says there are also planning and evaluation resources to help practices manage an effective campaign.
Vicki Farr, Equine Veterinary Advisor at MSD Animal Health said: "The recent outbreaks of equine flu have rocked the horse-racing world, costing the industry millions and raising important animal welfare issues. Furthermore, they have highlighted the need for good preventative healthcare and, in particular, vaccination.
"HHW will therefore come at a relevant time for horse owners and yards when the impact of equine flu is still at the front of their minds.
"This year HHW will provide vital tools for practices; building on the knowledge and resources we’ve acquired throughout the KBHH campaign and from previous HHWs.
"Our focus is on engaging owners and yards on understanding the risk of disease for their horse, while rewarding them for best practice. We are again providing a wide range of resources for practices to help them create an engaging and successful campaign that helps build knowledge amongst the equine community."
For further information, talk to your MSD Animal Health Equine Account Manager, call 01908 685685 or refer to KBHH social media feeds on Facebook page and Twitter (@keepinghorseshealthy).
Stronghold Plus contains the same selamectin found in common-or-garden Stronghold, licensed for the treatment of fleas, flea allergic dermatitis, ear mites (Otodectes cynotis), roundworm (Toxocara cati), intestinal hookworms (Ancylostoma tubaeforme), biting lice (Felicola subrostratus), and for the treatment of heartworm disease caused by Dirofilaria immitis.
To that has been added sarolaner, a new acaricide and insecticide which is also effective for five weeks against Ixodes ricinus, Ixodes hexagonus, and for four weeks against Dermacentor reticulatus and Rhipicephalus sanguineus.
Clint Lewis, Executive Vice President and President International Operations, said: "The launch of Stronghold Plus enables Zoetis to offer veterinarians in the European Union a new topical choice that treats the parasites commonly presenting a threat to cats with one convenient monthly dose.
For the first time, we have combined our new, versatile parasiticide sarolaner with the active ingredient in Stronghold, selamectin, resulting in the first approval of sarolaner for use in cats. We see sarolaner as a promising platform for future product lines and lifecycle innovations and are pleased with the positive data that sarolaner and its combination continue to generate in studies.”
Domenico Otranto, Professor of Parasitology at Bari University in Italy, who has reviewed the product data of Stronghold Plus, said: "A number of laboratory and field studies show the efficacy of the single spot-on application of Stronghold Plus for at least one month. Veterinarians in Europe now have a very effective option for the treatment and control of four prominent species of ticks commonly found on cats while maintaining proven efficacy against fleas, GI worms, heartworms, ear mites and lice. Ultimately, pet owners and practitioners have a new tool for improving health and welfare of cats."
VetHelpDirect.com, a website which helps pet owners decide how urgently their pet needs veterinary attention, has been relaunched with new content for donkey, reptile and bird owners.
Founded by VetSurgeon member Susie Samuel MRCVS in 2006, the site allows pet owners to look up the symptoms their animal is displaying. When the owner answers a series of simple, step-by-step questions, the site then generates a priority rating from "Self care - treatment at home" to "Urgent - you need to contact your vet immediately", coupled with specific first aid advice. It's a sort of home triage system.
VetHelpDirect was designed by vets and all of the content is by vets. The site covers dogs, cats, rabbits, horses and now donkeys, reptiles and birds. I see that the world-renowned avian vet (and all-round good bloke) Neil Forbes FRCVS and his team at Great Western Referrals, together with Dr Karen Rickards, head vet at the Donkey Sanctuary have helped create the new areas of the website, so the information it contains will certainly be of the highest standard.
In fact, the whole site is impressively well-designed and simple to use, an opinion obviously echoed by the readers of WebUser magazine, who gave it 5/5 stars last May, beating Jamie Oliver's website.
Cleverly, the triage system on VetHelpDirect ties in with a directory of veterinary practices, so if immediate care is the answer and the owner doesn't have a vet already, help is at hand. Veterinary practices can pay to have an enhanced listing in the directory.
For a fee, VetHelpDirect can also embed the triage system into your own practice website. That seems like a good way of adding additonal, interesting and interactive content to a website. The interesting question is how much money it will save the practice by eliminating unecessary calls from pet owners who don't really need to talk to a vet.
Equally, though, the site may have an important role to play in telling owners when they SHOULD get to the vet quickly. A recent success story was that of 'Bucket', a 5 year old cat from Nottingham. Bucket was fortunate to live after his owner Sarah Rennoldson logged on to Vet Help Direct.com after he displayed odd behaviour. Acting on the advice displayed on the site her owner immediately contacted her local vet Jaqui Gilmour MRCVS at Bill Bowlers Vets. Bucket was diagnosed with a blocked bladder, which was quickly operated on. Jaqui said: ' If Sarah hadn't brought Bucket in so quickly, he could have gone into renal failure and could have developed metabolic disturbances. He would have been really, really sore, and left untreated a blocked bladder can cause death.'
For more information, 'Start a Conversation' with Susie Samuel MRCVS
This, says the company, suggests that infection could be more common among seemingly healthy dogs than vets or owners realise, which may mean there is a greater risk of perioperative bleeding caused by the coagulopathies associated with A. vasorum2 than previously thought.
Elanco says another recent study indicates that there may be a bigger environmental risk for dogs than previously thought, too.
In the study, by Robbins et al, L3 larvae of A. vasorum and Crenosoma vulpis arising from the gastropod intermediate host were found to be immediately infective to dogs and remain so for up to eight weeks, meaning that dogs may only need to lick the molluscs’ slime to be at risk of infection.3
Elanco says this new data means A.vasorum should be added to many differential diagnosis lists, and that pre-operative testing could also be wise.
Jenny Helm, BVMS Cert SAM Dip-ECVIM CA FHEA MRCVS, European Specialist in Small Animal Internal Medicine, said: “Owners need to be aware that healthy dogs could be silently carrying and spreading the disease and that asymptomatic carriers could develop clinical signs at any time.
"They need to be aware that dogs don’t necessarily have to eat slugs and snails to become infected, as recent evidence suggest that other routes of transmission are possible.” To improve data on the prevalence of lungworm, Elanco has developed a version of its lungworm map specifically for veterinary surgeons, where you are invited to upload your cases (including asymptomatic positive cases: www.lungwormmap-vet.co.uk.
For those practices which want to run lungworm awareness campaigns in their area, Elanco has a how-to guide, posters and artwork available to download at www.myelanco.co.uk.
References
Matthew’s award is in recognition of his paper Approach to initial management of canine generalised epileptic seizures in primary-care veterinary practices in the United Kingdom, co-authored with Laurent Garosi, which was selected by the BSAVA Committee as being the most valuable to veterinary practice.
James’ study explored data collected as part of the Small Animal Veterinary Surveillance Network (SAVSNET) at the University of Liverpool.
In total, clinical records concerning 3,150,713 consultations (917,373 dogs) were collected and analysed from 224 UK veterinary practices.
This included the management of canine generalised epileptic seizures in 517 dogs up to 6 years of age.
The study concluded that 98% of dogs presenting for a single epileptic seizure were not started on long-term therapy, in accordance with the approach recommended by the International Veterinary Epilepsy Task Force (IVETF).
Other findings from the study included:
The paper also reported on factors potentially associated with prescription of ASDs.
It stated that dogs who presented for cluster seizures (more than one epileptic seizure in a 24-hour period) were more likely to be prescribed ASDs, or to be referred to a specialist, than dogs without cluster seizures.
Dogs that were neutered or microchipped were more likely to be started on ASDs following the initial presentation, perhaps suggesting that owners who take part in regular preventative healthcare prior to the onset of their dog’s seizures could be more willing to start therapy in the earlier stages of the disease.
In addition, more than half of dogs with cluster seizures were not prescribed any ASDs.
Given that the presence of cluster seizures is typically considered an indication to start long-term therapy by the IVETF, Matthew says this may be one aspect of seizure management that could be improved in primary care practice.
Regarding the choice of anti-seizure drugs (ASDs), imepitoin was more frequently prescribed than phenobarbital in response to cluster seizures.
But unlike phenobarbital, the paper highlighted that the market authorisation for imepitoin does not include the treatment of cluster seizures.
Therefore vets should be aware that the use of imepitoin for cluster seizures should be considered as “off-licence” - and has additional implications for obtaining informed consent.
Matthew said: “We believe this research contributes to an improved understanding of the current management strategies for canine epilepsy in general practice and how this compares to the current guidelines advised by the IVETF.
"Given the prevalence of epileptic seizures within the UK canine population, as well as the large proportion of dogs that will be managed entirely within general practice without referral to a neurologist, it is vital to ensure that the level of care being provided is optimal.
"We therefore hope that this research ultimately supports and guides general practitioners in their approach to canine epilepsy, thereby improving the quality of life of affected dogs and their owners.”
https://onlinelibrary.wiley.com/doi/epdf/10.1111/jsap.13543
The charity points out that with the arrival of winter, so comes an increase in the number of cats poisoned by antifreeze. For this reason, it has produced the poster to try and raise awareness of the fact that due to their specialised metabolism, a teaspoon or less of antifreeze can be enough to cause serious illness or death and even a curious lick of a small spillage can be enough to poison a cat.
The poster can be downloaded free of charge here: https://icatcare.org/sites/default/files/PDF/antifreeze-campaign-poster.pdf.
Alternatively, a hard copy can be ordered from the iCatCare shop for a small fee to cover postage: https://icatcare.org/product/antifreeze-poster
More information for pet owners can be found at: https://icatcare.org/advice/keeping-cats-safe/antifreeze
The guide has been written by Simon Tappin, European and RCVS Recognised Specialist in Veterinary Internal Medicine at Dick White Referrals, and is designed to offer practical advice on the appropriate use of antibiotics in general practice. It covers a range of topics including how to create an antibiotic practice policy, ways to optimise therapy and how to limit the development of antimicrobial resistance.
Simon said: "Making rational and informed antimicrobial choices is vitally important in veterinary medicine, both for the welfare of our patients and in reducing the risk of developing antimicrobial resistance.
"Highlighting this issue to vets, providing education and supporting them in making these decisions is crucial to ensure a responsible approach to antimicrobial prescribing."
Recent surveys have highlighted the need for education on this topic, with 63 per cent of vets1 stating that they would like to improve their knowledge on antimicrobials, and 90 per cent of vets2 admitting that they are concerned about antimicrobial resistance.
In addition, there's a quiz where you can test and your knowledge on antimicrobials, and enter a competition to win an iPad Pro. The quiz can be accessed at https://veraflox.typeform.com/to/KY8lxX.
The guide is available from the Bayer Vet Centre, www.vetcentre.bayer.co.uk. Alternatively, you can download it here www.bit.ly/Veraflox2016 or contact your local Bayer Territory Manager.
Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy.
Canine epilepsy can affect up to 5% of dogs6. In most dogs diagnosed with idiopathic epilepsy no underlying cause for the seizures can be found. While the condition can affect any dog, it is more common in young (one to five year old), purebred dogs such as Labradors, Golden Retrievers, German Shepherds, Boxers, Vizlas, Beagles, English Springer Spaniels, Irish Setters, Poodles and Dachshunds.
Boehringer says Pexion has a highly targeted mode of action1-3 to suppress a dog's seizures. It starts to work within a few hours and reaches steady state within three days4,5. Boehringer claims this will make it easier to stabilise epileptic patients. It also says there is no evidence of hepatotoxicity or liver-associated enzyme elevation, so repeated blood tests for liver enzymes or therapeutic levels are no longer required.4,5
Pexion is available in 100 mg and 400 mg tablets. The tablets are white, scored and divisible in half. Both tablet strengths are available in 100 tablet packs from veterinary wholesalers.
Jemima Mead, brand manager at Boehringer said: "Pexion is a ground-breaking new product which gives vets a new first-line treatment option for dogs with idiopathic epilepsy, improving the lives of newly diagnosed epileptic dogs and their owners by reducing the number of seizures and their impact on the patient's life".
To support the launch of the new product, Boehringer hosted an epilepsy webinar presented by neurologist Dr Holger Volk DVM PhD DipECVN FHEA MRCVS, recognised RCVS and European Specialist in Veterinary Neurology. The webinar is now available on demand at www.bi-academy.co.uk.
For further information on Pexion visit www.pexion.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
Dr Radev faced three charges concerning his treatment of an American Bulldog in 2021.
The first charge, which contained a number of sub-charges, was that he failed to provide appropriate and adequate care to the animal.
The second was that he failed to keep adequate records.
The final charge was that his failure to keep records was misleading and dishonest.
At the outset of the hearing Dr Radev admitted that, having recognised free fluid in the dog’s abdomen, he failed to take adequate and appropriate action and failed to aspirate the dog’s abdomen with regards to the possibility of it having septic peritonitis.
He also admitted writing the clinical notes approximately two months after the event.
After considering and rejecting an application by the RCVS to amend and withdraw elements of the first charge, the Committee then considered each of the remaining sub-charges in turn.
Sub-charge 1(a) was that Dr Radev repeatedly administered meloxicam to the dog when it had recently undergone intestinal surgery and had a recent history of vomiting.
The Committee found that this was not proven.
Dr Radev said it had been administered just once and the Committee was not satisfied so as to be sure that it was repeatedly administered.
Sub-charge 1(b) (i) was that Dr Radev failed to recognise free fluid in the dog’s abdomen as shown on an ultrasound scan.
The Committee found this not proven.
Sub-charge 1(c) (i) was that Dr Radev failed to recognise the possibility of septic peritonitis in the dog.
Sub-charge 1(e) was that Dr Radev failed to provide a full medical history when referring the dog to a different practice.
The Committee found the charge not proven.
Regarding charge 2 (ii), that Dr Radev had failed to include in clinical records a reference to the colonotomy surgery, the Committee found this charge not proven as it had been provided with clinical records disproving this charge.
Finally, regarding both aspects of charge 3, namely that Dr Radev had acted misleadingly and dishonesty, the Committee found this not proven.
The Committee then considered whether the charges that Dr Radev had admitted amounted to gross misconduct in a professional respect.
In all cases it found that, while Dr Radev’s conduct had fallen below what was expected of veterinary professionals, it did not fall so far below as to constitute serious professional misconduct.
www.rcvs.org.uk/disciplinary
Vetoquinol has announced the launch of its new support package to help vets and owners manage canine epilepsy with Epiphen, the company's phenobarbital medication.
Each Epiphen support package contains:
Accurate information is vital to help control epilepsy patients and the Owner Record Manual will enable owners to keep on top of this information. It contains charts to monitor seizure frequency and patterns, medication changes, blood test results and seizure characteristics.
The new "ask the expert" scheme offers vets the opportunity to ask for advice on epilepsy cases. Email epiphen@vetoquinol.co.uk with the query (and your contact details) and you will be put in touch with a neurology expert at a leading referral centre. Vets can also contact the Technical Helpline on 0800 1698197.
The Seizure Reports for vets provide a much more detailed tool for use at initial presentation or for owners to fill in when seizures differ in character. There is a pad of 30 tear-off sheets in each Epiphen support package.
Simon Boulton, Epiphen product manager said: "We understand that epilepsy is an emotional condition and wanted to provide vets and owners with more than just a tablet. I am convinced that with the Epiphen Support Package we are providing them with the tools they need to make the most of epilepsy management."
Epiphen also offers a free phenobarbital monitoring service. There is a voucher in each 30mg pack and 2 in each 60mg pack.
For more details on the Epiphen Support Package, to obtain a free practice starter pack or get extra copies of materials, please contact Vetoquinol on 0800 1608197 or contact your Vetoquinol representative.
Velactis (cabergoline) is a POM marketed by Ceva Animal Health, used in the herd management programme of dairy cows as an aid in abrupt drying-off, by reducing milk production.
The product was authorised through the European Medicines Agency (EMA) in December 2015 and was first sold in the UK in April 2016.
The VMD says it has been made aware of reports of serious adverse events, predominantly occurring in Denmark, involving recumbency (lying down and unable to rise) and some deaths. Most adverse events occurred within 8 to 24 hours following product administration. Anecdotal evidence suggests that hypocalcaemia treatments may be successful in reversing clinical signs.
Ceva has decided to stop further distribution of the product in Europe voluntarily, pending the outcome of further investigations to assess a possible causal link between the product and the adverse events reported.
The VMD, EMA, other agencies throughout Europe and the MAH are working closely to monitor the situation.
The VMD highlights that due to the nature and use of the product there is no risk to human health or consumer safety.
Vets and dairy farmers are strongly encouraged to report any adverse events associated with use of Velactis to the VMD using its online reporting form or directly to Ceva for further investigation by the MAH as necessary.
Tony Noble, managing director at Noble Futures, said: "We have been working with organisations of all shapes and sizes since our foundation in 2002 and it became clear that while we can ensure that our clients recruit the top people for the job - through finding them the best permanent, contracting or temporary employees - the resources are not always present to ensure that this human resource potential is maximised. The team at The Partners deliver a world-class service and we are 100% confident that their professional and expert support services will make a real difference to our clients’ businesses."
Noble Futures and The Partners have launched three new services:
The Human Resources support service is aimed at organisations that need additional support or more expert advice within the human resources function, whether it relates to a particular employee issue such as managing a long-term illness, or a wider corporate challenge like implementing a company-wide performance management system.
The Psychometric Profiling service is designed to give unique insights into the individual traits of employees, to help with recruitment, promotion, coaching and career development.
Finally, the Management Development service has been developed to help ensure a company’s employees receive the right training for success.
Paula Summerscales (pictured right with husband Graham) from The Partners said: "We are delighted to partner with Noble Futures to deliver our range of people-building services to organisations in the animal health sector. Our unique mix of skills and experience allows us to bring a tailored approach to every single project we work on and we’re looking forward to working with Noble Futures clients to implement innovative solutions that gain commercial results."
For more information, contact Noble Futures on 0161 820 3510 or email: info@noble-futures.com.
Alternatively, contact The Partners directly on 01484 860849
Richard was elected to RCVS Council in 2020, having previously served as an elected member from 2008 to 2016.
Over the years, he has also been a significant and valued contributor to VetSurgeon.org, and his insight will be missed.
RCVS President Mandisa Greene said: “We thank Richard for his service to the RCVS over the past year and in his previous terms. We particularly thank him for his contribution to a number of committees he has served on during both his periods on Council including the Disciplinary, Finance & Resources and Preliminary Investigation Committees. We wish him all the best for the future.”
Professor Stephen May has now taken up the remainder of Richard’s term on Council, to July 2024, as he received the next largest amount of votes in the 2020 RCVS Council election.
The company says Cevaprost can help improve breeding success in reproduction protocols in cattle and has the following indications:
Ceva says these indications are equivalent to those of the leading racemic and single isomer cloprostenols available in the UK.
Cevaprost is available in a 20ml colourless glass vial and in a multi-pack of 10 x 20ml vials. It can be administered in single or repeated 2ml doses (equivalent to 0.5mg of cloprostenol) by intramuscular injection. It has a withdrawal period of one day for meat and no withdrawal period for milk.
Peter Keyte, ruminant business unit manager at Ceva Animal Health, said: “We are delighted to add Cevaprost to our extensive range of reprodAction products to provide vet and farmers with comprehensive cattle reproduction solutions and improve breeding success in reproduction protocols.”
For further information, contact your local Ceva territory manager or email cevauk@ceva.com.
Consequently, the company says the sheep sector is going to have to take a more proactive approach to parasite control if it is to achieve the best possible environmental standards.
The research by SRUC and the Moredun Research Institute showed parasite infections in lambs can lead to a 33% increase in methane output1 and that parasitism is one of the top three livestock diseases which increase greenhouse gas (GHG) emissions2 and is cost-effective to manage.
Eurion Thomas, European operations manager at Techion, says that despite current emissions from sheep being over-exaggerated, the sector will need to act if the NFU’s aspiration for net zero emissions from agriculture by 2040, is to be achieved.
Eurion said: "While targets to further reduce GHG emissions may appear to be burdensome, there are some simple steps farmers can take that’ll help minimise emissions while also improving business profitability. This includes incorporating regular faecal egg counts (FEC) into routine flock management to increase the accuracy of worm control.
"Worms reduce performance, in particular feed conversion ratio (FCR) meaning animals take longer to finish at lower weights. In addition, the research shows animals with worms release more methane per day due to the upset they cause to the digestive system.
"Better parasite control can therefore reduce number of days to finishing, improving production efficiency and lowering methane emissions per unit of meat produced. The number of days to slaughter and FCR are also correlated to profit margins, providing an opportunity to improve the bottom line."
Eurion says one of the reasons endemic diseases such as worm burdens are so detrimental to production efficiency and emissions is because often the disease has significantly impacted animal performance before it has been identified. Regular faecal egg counts (FEC) and an accurate treatment programme are therefore crucial.
Eurion said: "FECPAKG2 is the latest in image-based, internet-connected, FEC technology and means testing can be carried out virtually anywhere by anyone, including on-farm by the farmer.
"Because digital images of parasite eggs are produced, analysed and stored online, FECPAKG2 provides rapid results while offering greater quality control and auditability. This is encouraging more frequent testing and better decision making at farm level."
A collaborative research project between Sainsbury’s and Techion3 showed accurate treatment of the right animals, with the right wormer, at the right time, improved daily liveweight gains (DLWG) while reducing wormer use in sheep by up to 50%.
Eurion said: "Addressing the environmental impact of red meat production is arguably one of the biggest challenges the sector faces and introducing FEC is one simple way farmers can proactively work towards this, while improving business profitability."
Micro-nutrition specialist Agrimin has launched All-Trace Biotin Gold, the seventh bolus in the company's All-Trace range.
The new bolus is the result of extensive in-house research and development which aimed to formulate a cost-effective, micro-nutrition bolus suitable for dry cows and heifers at risk from lameness, which affects up to 20 per cent of the UK national herd. According to Agrimin, the relationship between Biotin and its benefits on ruminant hoof health is receiving increasing attention. The company says it is the first micro-nutrition specialist to directly address this livestock health issue by using a bolus.
The Biotin Gold bolus for dairy cows and heifers delivers the target level of 20 mg per head, per day of Biotin over 120 days. In addition, the bolus also delivers the full, daily requirement of copper, cobalt, selenium and iodine as well as levels of zinc, manganese and vitamins A, D3 and E.
Administration is simple and convenient during the drying off period as many livestock are already going through a crush to have their feet trimmed and undergo other healthcare routines such as intramammary treatments.
For dry cows, two boluses are given to each cow at the point of drying off. They lie in the rumen/reticulum and slowly dissolve from a constant surface area providing a continuous and regular supply of trace elements and vitamins to the animal. The boluses dissolve completely and leave no residue in the rumen.
Agrimin says heifers respond very well to Biotin supplementation and studies have shown that supplying Biotin in the later stages of pregnancy produces the most effective results. This late stage of pregnancy is also the critical period for the transfer of vital nutrients from mother to calf and so the trace element content of All-Trace Biotin Gold will benefit both animals. Two boluses are given to each heifer at around three months pre-calving.
All-Trace Biotin Gold is available in packs of 20 boluses, which will supplement 10 cows or heifers at a cost of around £9.50 per animal for two boluses. For more information about bolus technologies and micro-nutrition, please visit www.agrimin.com or call 01652 688046.
The Royal College of Veterinary Surgeons is warning veterinary surgeons to be on their guard after it came to light that a fraudster is charging a £150 'non-refundable application fee' for an RCVS 'internship' which does not exist. Apart from anything else, the RCVS does not offer internships.
Information about the fake internship has been sent to individuals registered with German website http://www.vetcontact.com/. It includes details about the Royal Veterinary College and the RCVS, but is basically fiction. It refers to a made up 'RCVS Hospital' in the 'Flint Hills of London'.
Gordon Hockey, RCVS Head of Professional Conduct said: "So far, only a handful of veterinary surgeons - all based overseas - have contacted us regarding the internship and queried the request for a non-refundable 'application' fee, although we are concerned that others may have been caught out.
"We would advise any veterinary surgeon to think twice before paying for a third party to facilitate an application for any placement or internship, and reiterate that the RCVS does not offer any such programmes."
The College is following up the situation with http://www.vetcontact.com/ and, if appropriate, will notify the police. In the meantime, anyone who is concerned that they may have fallen victim to the hoax should contact the RCVS Professional Conduct department on 020 7202 0728.
The expansion has increased the hospital's footprint by 30%, adding three new operating theatres, six new consult rooms and new feline facilities, including a cat-only waiting room, consult room and treatment area.
Hospital owner, IVC Evidensia said the expansion has been driven in part by the pet ownership boom of the last few years and increased demand for the hospital’s services.
To meet the demand, Vale has expanded its office space, adding desk space for a further 25 vets.
There are also new ultrasound and cardiology rooms, a new dental suite and enlarged prep and recovery areas.
The existing kennel area has doubled in size with the addition of nine new walk-in kennels, a bespoke isolation ward and secure outdoor runs.
Richard Artingstall, clinical director at Vale Referrals, said: “We’ve been working on this expansion for a long time and it’s incredible to see it complete.
"Our new and improved facilities mean we can give even more pets across the Southwest the gold standard treatment that they deserve and support our colleagues from neighbouring vet practices with extensive referral services.
"The feedback from pets and owners so far has been very rewarding to hear.”
The feedback from pets?
Really?
VetSurgeon.org contacted recent patient Dougal McDoggins for comment.
He said: "Woof."
www.valereferrals.co.uk.
The researchers say that research thus far has focused on developing treatments to manage idiopathic epilepsy and little attention has been given to the emotional and logistical challenges for owners managing their dog’s condition.
This study used semi-structured interviews to explore how owners’ lives were changed following their dogs’ diagnosis and glean in-depth insights into their lives.
The research discovered that following their dog’s initial seizure, all interviewees recalled feeling negative emotions such as being distraught, fearful or uncertain regarding their dog’s future and disease progression. Prior experience with canine epilepsy was rare, and owners were shocked and distressed by the appearance of their dog’s seizures.
Whilst many owners discussed a very emotionally close dog-owner bond, owning a dog with epilepsy had a significant impact on their lifestyle. Impacts affected many aspects of daily routines, and in some cases, owners’ jobs. The unpredictable and sometimes inconvenient timing of seizures negatively impacted owners’ sleep and wellbeing. This unpredictability also made some owners feel that they were living with “a ticking time bomb”.
Other limitations included strict daily medication schedules and difficulty finding assistance in caring for their dog. This, combined with a fear of leaving their dog unsupervised, had social implications in some instances and led to increased use of the Internet and online groups for peer support. Owners also reported that friends, family and colleagues did not always understand the magnitude of commitment required.
Amy Pergande, Small Animal Intern at the RVC and primary author of the study, said: "We are sincerely grateful to the owners who participated in this study for providing us with such detailed and often emotive accounts of their experiences. Many of the participants had willingly altered many aspects of their daily routine for their dogs, both socially and professionally, and sometimes at the expense of their own quality of life."
This research highlights that further consideration of these factors by veterinary professionals and the friends and families of owners of these dogs could improve owner quality of life and facilitate the provision of additional, much needed support.
Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science and research lead in canine epilepsy at the RVC, said: "Epilepsy can be an extremely tough condition for owners to manage, where the love, time and money owners dedicate to their dogs is not necessarily matched by a significant improvement in their condition, with seizures often continuing unabated. Our study has revealed previously unrecognised or under-appreciated impacts that epilepsy introduced to these owners’ lives. Improved awareness and understanding of these challenges by veterinary professionals have the potential to improve communication with clients, to avoid owners feeling that social media is the only place they can go to feel supported and understood”.
These findings increase the understanding of the sometimes negative and often profound emotional effects and lifestyle changes experienced by owners managing a dog with idiopathic epilepsy. With better support and resources, the reported impacts could potentially be minimised to protect owner quality of life.
Zoe Belshaw, independent research collaborator, said: “The welfare of pets and their owners can be closely intertwined. This research exploring how owners’ lives change when their dogs develop epilepsy is another important piece in the jigsaw of understanding both what the veterinary profession can do to best support our clients, but also in starting to appreciate the substantial wider societal impacts of chronic ill health in our nations’ pets”.
The full paper is open access and available at: https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-020-02669-w
Reference
Photo: The Melias Studio
Vet Futures, the joint initiative by the RCVS and BVA to stimulate debate about the future of the profession, has opened a new discussion hospice care, and whether it it will become mainstream in veterinary medicine.
This month's Vet Futures guest blogger, Kath Dyson, a former veterinary surgeon who qualified from Glasgow in 1989, writes that veterinary palliative care, while a relatively recent phenomenon, has been growing in stature, particularly in the United States, with symposia and conferences on the subject as well as webinars and chapters in text books.
She notes the increasing number of UK vets offering hospice care, highlighting the differences between palliative services offered in human and veterinary medicine as well as debates within the profession over the advantages and disadvantages of palliative care versus euthanasia.
She said: "In animal hospice it is the pet's owner who takes on all the financial, practical and emotional costs involved, whereas human patients have a lot more support available. Euthanasia is always an option in veterinary medicine, and indeed euthanasia of an animal can legally be carried out by anyone, so long as it is done humanely."
On the euthanasia debate she adds: "Some regard euthanasia as more of a last resort, with hospice assisted natural death being seen as more preferable and only a minority of patients requiring euthanasia. Others feel that euthanasia is more often likely to be the preferable outcome of a period of hospice care in the animal patient, even though they do not rule out a natural death."
Overall she argues that additional expertise from veterinary surgeons in end of life care will help the profession be "even better able to provide truly lifelong care to all their animal patients".
To accompany Kath Dyson's article, this month's poll asks if hospice care will become a standard part of practice.
Last month's poll asked if vets are given adequate information, guidance and support on ethnic and cultural diversity in relation to a blog written by a British Asian vet about prejudice he encountered from a client. The vast majority (90%) of the 118 people who responded to the poll thought that the profession was lacking in support when it came to diversity. Diversity in the profession and how to increase it has been a key topic identified by the project and it will be one of the issues addressed in the final Vet Futures Report published later this year.
To take part in this month's poll and to read and comment on Kathy Dyson's blog visit www.vetfutures.org.uk/discuss